The document discusses amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive neuromuscular condition that affects motor neurons in the brain and spinal cord. Key symptoms include muscle weakness, atrophy, spasms, and increased reflexes. While sensory and cognitive functions remain intact, over time patients have increasing problems with movement, swallowing, speaking and breathing. There is currently no cure for ALS, though treatments aim to reduce symptoms and multidisciplinary care can help prolong life expectancy and quality of life. Occupational therapy focuses on maintaining independence through adaptive equipment and strategies.
Amyotrophic lateral sclerosis (ALS) is a rare neurological disease that primarily affects the nerve cells (neurons) responsible for controlling voluntary muscle movement (those muscles we choose to move). Voluntary muscles produce movements like chewing, walking, and talking.
amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease Medical Students
Gehrig's disease ALS motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles.
Motor neuron disease is a rare disease it doesn't have any cure here in this video I have tried playing what is mnd its types causes how to diagnose and its management plan
Amyotrophic lateral sclerosis (ALS) is a rare neurological disease that primarily affects the nerve cells (neurons) responsible for controlling voluntary muscle movement (those muscles we choose to move). Voluntary muscles produce movements like chewing, walking, and talking.
amyotrophic lateral sclerosis & Gehrig's disease & moror neuron disease Medical Students
Gehrig's disease ALS motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles.
Motor neuron disease is a rare disease it doesn't have any cure here in this video I have tried playing what is mnd its types causes how to diagnose and its management plan
Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases that cause progressive weakness and degeneration of skeletal muscles used during voluntary movement. The word dystrophy is derived from the Greek dys, which means "difficult" or "faulty," and troph, or "nourish." These disorders vary in age of onset, severity, and pattern of affected muscles. All forms of MD grow worse as muscles progressively degenerate and weaken. Many patients eventually lose the ability to walk.
Some types of MD also affect the heart, gastrointestinal system, endocrine glands, spine, eyes, brain, and other organs. Respiratory and cardiac diseases may occur, and some patients may develop a swallowing disorder. MD is not contagious and cannot be brought on by injury or activity.
Here is very good and amazing presentation on Multiple sclerosis ..its about brain
read this carefully and work on this because the work on brain is very good for future research...
Amyotrophic lateral sclerosis (ALS), AKA "Lou Gehrig's Disease," is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body. The progressive degeneration of the motor neurons in ALS eventually leads to their death. When the motor neurons die, the ability of the brain to initiate and control muscle movement is lost. With voluntary muscle action progressively affected, patients in the later stages of the disease may become totally paralyzed.
Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases that cause progressive weakness and degeneration of skeletal muscles used during voluntary movement. The word dystrophy is derived from the Greek dys, which means "difficult" or "faulty," and troph, or "nourish." These disorders vary in age of onset, severity, and pattern of affected muscles. All forms of MD grow worse as muscles progressively degenerate and weaken. Many patients eventually lose the ability to walk.
Some types of MD also affect the heart, gastrointestinal system, endocrine glands, spine, eyes, brain, and other organs. Respiratory and cardiac diseases may occur, and some patients may develop a swallowing disorder. MD is not contagious and cannot be brought on by injury or activity.
Here is very good and amazing presentation on Multiple sclerosis ..its about brain
read this carefully and work on this because the work on brain is very good for future research...
Amyotrophic lateral sclerosis (ALS), AKA "Lou Gehrig's Disease," is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body. The progressive degeneration of the motor neurons in ALS eventually leads to their death. When the motor neurons die, the ability of the brain to initiate and control muscle movement is lost. With voluntary muscle action progressively affected, patients in the later stages of the disease may become totally paralyzed.
ITS 833 – INFORMATION GOVERNANCEChapter 7Dr. Omar Mohamed.docxdonnajames55
ITS 833 – INFORMATION GOVERNANCE
Chapter 7
Dr. Omar Mohamed
Copyright @ Omar Mohamed 2019
1
1
Chapter Goals and Objectives
What is the difference between structured
What is the difference between unstructured and semi-structured information?
Why is unstructured data so challenging?
Copyright @ Omar Mohamed 2019
2
Generally, what is full cost accounting (FCA)?
What are the 10 key factors that drive the total cost of ownership of unstructured data
How can we better manage information?
How would an IG enabled organization look different from one that is not IG enabled?
2
The Business Case for
Information Governance
Difficult to Justify
Short term return on investment is nonexistent
Long term view is essential
Reduce exposure to risk over time
Improve quality and security of information
Streamlining information retention
Looking at Information Costs differently
Copyright @ Omar Mohamed 2019
3
3
The information environment
Challenges of Unstructured Information
Data volumes are growing
“Unstructured Information” is growing at a dramatic rate
Challenges unique to unstructured information
Horizontal nature
Lack of formality
Management location
Identification of ownership
Classification
Copyright @ Omar Mohamed 2019
4
Calculating Information Costs
Rising Storage Costs (Short sighted thinking)
Labor (particularly knowledge workers)
Overhead costs
Costs of e-discovery and litigation
Opportunity Costs
4
Full Cost Accounting for
Information Models
Total Cost of Ownership (TCO) Model
Return on Investment Model (ROI)
Full Cost Accounting Model (FCA)
Past, Present, Future Costs
Direct Costs
Indirect Costs
Flexible Application
Triple Bottom Line Accounting – Monetary, Environment, Societal Costs
Copyright @ Omar Mohamed 2019
5
Full Cost Accounting
General and Administrative Costs
Productivity Gains and Losses
Legal and E-discovery costs
Indirect Costs
Up-Front Costs
Future Costs
5
The politics involved
Tools needed to establish facts about the information environment
SOURCES OF Costs of owning unstructured information, cost reducers, and cost enhancers
Giving unstructured information value
The IG enabled organization
The End
Copyright @ Omar Mohamed 2019
11
11
Brain, Behavior, and Immunity 64 (2017) 59–64
Contents lists available at ScienceDirect
Brain, Behavior, and Immunity
journal homepage: www.elsevier.com/locate/ybrbi
Short Communication
Constriction of the buccal branch of the facial nerve produces unilateral
craniofacial allodynia
http://dx.doi.org/10.1016/j.bbi.2016.12.004
0889-1591/� 2016 Elsevier Inc. All rights reserved.
⇑ Corresponding author at: Department of Psychology, Campus Box 345, Univer-
sity of Colorado at Boulder, Boulder, CO 80309-0345, USA.
E-mail address: [email protected] (L.R. Watkins).
1 Authors contributed equally to this work.
2 Current address: Department of Critical Care Research, University of Texas MD
Anderson Cancer Center, Houston, USA.
Susannah S. Lewis a,1, P.
the presentation gives a detail information about the seronegative spondyloarthropathy. this ppt also provide recent evidences to frame the rehab protocol.
Amyotrophic Lateral Sclerosis based on "The Theory of Everything"Sarentha Luther
This presentation is a synopsis of Amyotrophic Lateral Sclerosis based on the perspective of the movie; "The theory of Everything". This is part of the online course "Understanding the Brain: The Neurobiology of Everyday Life" with the University of Chicago through Coursera.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. ALS also known as Lou Gehrig’s Disease or Motor Neuron
Disease (MND).
ALS was first described in 1869 by Jean-Martin Charcot, a
French neurologist.
And was brought to national attention once baseball
legend, Lou Gehrig was diagnosed with the disease in
1939.
3. It is a life threatening disease that negatively affects
millions of people each year.
It is a progressive neuromuscular condition
characterized by muscle weakness
(hypotonicity), muscle wasting (atrophy), muscle
twitching (fasciculation), and increase reflexes
(hyperreflexia) (Aebischer & Kato, 2007).
The progression of the disease is different from one
person to the next.
Important! This a motor neuron disease;
sensory, executive functions, and intellect remain
intact.
4. The cause of ALS remains unknown. Theories to the cause
of such disease are thought to be
genetic, viral, autoimmune disorder.
Enzyme deficiency, environmental factors, and neurotoxic
hypothesis (Benot-Abreu, Damme, Van Den Bosch &
Robberecht).
Research postulates concern over neurotoxicity relating to
abnormalities of essential neurotransmission
anions, calcium and glutamate, entering the
neuron, damaging the cell metabolism, and resulting in
pathological changes (Wijesekera & Leigh, 2010).
5. A report on incidence shows that ALS on average affects 1.89
per 100,000 a year and prevalence average of 5.2 per 100,000
(King, Duke, & O’Conner, 2009).
The mean age of onset for ALS is about 60 yrs, with a slight
male prevalence male/female ratio 1.5:1
Approximately 2/3 of patients with typical ALS have a spinal
form of the disease where the symptoms may start either
distally or proximally in the UE and LE (King, Duke, &
O’Conner, 2009).
Most common motor neuron disorder in adults (Atchison &
Dirette, 2007).
6. Depend on the location of the disease ALS divides
into three areas: lower motor neuron, corticospinal
tract, and corticobulbar tract dysfunction
Regardless the part of the body first affected by the
disease, muscle hypotonicity and atrophy spread to
other somatic effectors as the disease progresses
(Atchison & Dirette, 2007).
Patients have increasing problems with
moving, swallowing (dysphagia), and speaking or
forming words (dysarthria) (Wijesekera &
Leigh, 2010).
7.
8.
9. Patients must have signs and symptoms of both
upper and lower motor neuron damage, that’s not
attributed to other causes.
The process consists of a history and physical
exam, repeated at regular intervals, to document
hyperreflexia, fasciculation, and upper and lower
movement (Bento-Abreu, et. al, 2010).
MRI tests document denervation and distinguish
benign fasciculation from those of ALS (Atchison
& Dirette, 2007).
10. Currently there is no known medical cure to alter the fatal
progression of ALS.
Gradual death 1-5 years from diagnosis due to
respiratory problems, though course is progressive and
rapid.
Riluzole remains to be the only compound licensed for
use since it reduces damage to motor neurons by
decreasing the release of glutamate and modifies the
rate of evolution (Corcia & Meininger, 2008).
Anti-inflammatory medications
Antispasmodic
Non-invasive ventilator support
Multidisciplinary teams (including OT) may increase
quality and length of life.
11. Occupational Therapy provides a longer duration and
better quality of life (QOL).
Providinghope for patients retaining purpose in
occupational activity (Corcia & Meininger, 2008)
Prescribingappropriate equipment, which helps with
functional independence within areas of occupation
(AOTA, 2008) .
12. Assistive technology and equipment commonly
recommended to minimize energy output and improve
performance with self care tasks and other ADLs:
Reachers
Dressing sticks
Long handle shoehorns
Long handle sponges
Buttonhooks
Shower seats
Three-in-one commodes
14. The cause of ALS remains unknown and most common motor
neuron disorder in adults
Important! This a motor neuron disease; sensory, executive
functions, and intellect remain intact.
Symptoms include: muscle
spasticity, hypotonicity, atrophy, cramps, fasciculation and
hyperreflexia. Also, dysphagia, dysarthria, and an overactive gag
reflex.
Treatments include: Anti-inflammatory and Antispasmodic
medications. Also, non-invasive ventilator support
Multidisciplinary teams (including OT) may increase quality and
length of life.
Death from respiratory failure, 1-5 years after Diagnosis due to rapid
and progressive nature of the disease.
15. Aebischer, P., & Kato, A. C. (2007). Playing defense against Lou Gehrig’s disease. Scientific
American, 297(5), 86-93. Retrieved from EBSCOhost.
American Occupational Therapy Association. (2008). Occupational therapy practice
framework: Domain and Process (2nd ed.). American Journal of Occupational Therapy, 62,
625-683
Atchison, B. J., & Dirette, D. K. (2007). Conditions in Occupational Therapy (3rd ed., pp.
268-271). Baltimore, MD: Lippincott Williams & Wilkins.
Bento-Abreu, A., Van Damme, P., Van Den Bosch, L., & Robberecht, W. (2010). The
neurobiology of amyotrophic lateral sclerosis. European Journal of Neuroscience, 31(12),
2247-2265. doi:10.1111/j.1460-9568.2010.07260.x
Corcia, P., & Meininger, V. (2008). Management of amyotrophic lateral sclerosis. Drugs,
68(8), 1037-1048. Retrieved from EBSCOhost.
King, S. J., Duke, M. M., & O'Connor, B. A. (2009). Living with amyotrophic lateral
sclerosis/motor neurone disease (ALS/MND): decision-making about ‘ongoing change and
adaptation’. Journal of Clinical Nursing, 18(5), 745-754. doi:10.1111/j.1365-
2702.2008.02671.x
Wijesekera, L. C., & Leigh, P. N. (2009). Amyotrophic lateral sclerosis. Orphanet Journal of
Rare Disease, 4(3), 1-22. doi:10.1186/1750-1172-4-3